Public source

Reviewed 21 Jul 2026

Completeness Fair (31%)

Ibex Breast

IBEX

Ibex Breast assists pathologists in breast biopsy and excision diagnosis by improving the detection and grading of cancer and other clinically relevant features. The AI model detects 54 tissue morphologies. The model's aims are:
• Triaging with tagged case-level & slide-level AI findings
• Optimization with IHC pre-ordering based on AI findings
• Increased accuracy with AI-powered heatmaps detecting invasive cancer & ADH/DCIS
• Increased consistency with AI-powered heatmaps for ILC, IDC & DCIS grading
• Quick and accurate identification of microinvasions, lobular neoplasia, microcalcifications, LVI & TILS

Supported by 3 papers

General Information

Product name

Ibex Breast

Company

Modality

Histopathology

Main task

Detection, Grading, Triage

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Biopsies, Excisions

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Aug 1, 2025 | Last updated: Jul 21, 2026